[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
argenex Q1 Earnings Call Highlights

argenx (NASDAQ:ARGX) reported first-quarter 2026 results highlighting continued commercial growth for VYVGART and progress across multiple late-stage pipeline programs, while newly appointed CEO Karen...

ARGX : 782.17 (-0.65%)
Argenx Reports Tomorrow With Analysts Apparently Forgetting What Biotech Valuations Mean

Barchart Research What to Expect from ARGX Earnings ARGX Generated May 6, 2026 Current Price $807.55 EPS Estimate $$5.16 Consensus Rating Strong Buy Average Move 4.81% Argenx Reports Tomorrow With Analysts...

ARGX : 782.17 (-0.65%)
argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada

TORONTO , Nov. 5, 2025 /CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today...

ARGX : 782.17 (-0.65%)
Analysts Offer Insights on Healthcare Companies: Microbot Medical (MBOT), Argenx Se (ARGX) and AnaptysBio (ANAB)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Microbot Medical (MBOT – Research Report), Argenx Se (ARGX – Research Report) and AnaptysBio (ANAB –...

ANAB : 69.33 (+3.54%)
ARGX : 782.17 (-0.65%)
MBOT : 2.13 (unch)
Argenx SE Showcases Immunology Innovations at 2025 AANEM Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

ARGX : 782.17 (-0.65%)
TD Cowen Remains a Buy on Argenx Se (ARGX)

In a report released today, Yaron Werber from TD Cowen reiterated a Buy rating on Argenx Se, with a price target of $800.00. The company’s shares closed yesterday at $812.95.Elevate Your Investing Strategy:...

ARGX : 782.17 (-0.65%)
Argenx Se (ARGX) Gets a Buy from Evercore ISI

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Argenx Se yesterday and set a price target of $775.00. The company’s shares closed yesterday at $799.56.Elevate Your Investing Strategy:...

ARGX : 782.17 (-0.65%)
RBC Capital Remains a Buy on Argenx Se (ARGX)

In a report released on October 8, Luca Issi from RBC Capital maintained a Buy rating on Argenx Se. The company’s shares closed yesterday at $804.90.Elevate Your Investing Strategy: Take advantage of...

ARGX : 782.17 (-0.65%)
Argenx SE Calls Extraordinary Shareholder Meeting for November 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Argenx Se...

ARGX : 782.17 (-0.65%)
Goldman Sachs Sticks to Its Buy Rating for Argenx Se (ARGX)

Goldman Sachs analyst maintained a Buy rating on Argenx Se today and set a price target of $916.00. The company’s shares closed yesterday at $767.33.Elevate Your Investing Strategy: Take advantage of...

ARGX : 782.17 (-0.65%)

Barchart Exclusives

JPMorgan vs. Bank of America: How the 2 Dividend-Paying Bank Stocks Stack Up in 2026
JPMorgan dominates on scale and profits, while Bank of America wins on value and yield. Here's which big bank stock deserves your money in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.